RT Journal Article
SR Electronic
T1 Proactive social distancing mitigates COVID-19 outbreaks within a month across 58 mainland China cities
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.22.20075762
DO 10.1101/2020.04.22.20075762
A1 Du, Zhanwei
A1 Xu, Xiaoke
A1 Wang, Lin
A1 Fox, Spencer J.
A1 Cowling, Benjamin J.
A1 Galvani, Alison P.
A1 Meyers, Lauren Ancel
YR 2020
UL http://medrxiv.org/content/early/2020/04/29/2020.04.22.20075762.abstract
AB In early 2020, cities across China enacted strict social distancing measures to contain emerging coronavirus (COVID-19) outbreaks. We estimated the speed with which these measures contained community transmission in each of 58 Chinese cities. On average, containment was achieved 7.83 days (SD 6.79 days) after the implementation of social distancing interventions, with an average reduction in the reproduction number (Rt) of 54.3% (SD 17.6%) over that time period. A single day delay in the implementation of social distancing led to a 2.41 (95% CI: 0.97, 3.86) day delay in containment. Swift social distancing interventions may thus achieve rapid containment of newly emerging COVID-19 outbreaks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge the financial support from NIH (U01 GM087719) and the National Natural Science Foundation of China (61773091).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot applicable